Dawu Y. Zeng
Fuzhou, 350005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Single-cell and bulk transcriptome analysis unveils a ligand-receptor-based signature for prognostication and reveals that TREM1 controls the malignant behaviors of hepatocellular carcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: June 24, 2025
The lignan compound matairesinol monoglucoside induces type I interferon production in HBV infection immunity by regulating STING signaling.
Journal: RSC medicinal chemistry
Published: May 23, 2025
Cumulative Hepatitis B Surface Antigen/Hepatitis B Virus DNA Ratio in Immune-tolerant Hepatitis B Patients: A 10-year Follow-up Study.
Journal: Journal of clinical and translational hepatology
Published: May 06, 2025
Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
Journal: Alimentary pharmacology & therapeutics
Published: December 08, 2024
Effect of dyslipidemia on HBsAg clearance in nucleos(t)ide analogues-experienced chronic hepatitis B patients treated with peginterferon alfa.
Journal: BMC infectious diseases
Published: August 09, 2024
Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α.
Journal: Therapeutic advances in gastroenterology
Published: June 30, 2024
Etiology and Prognostic Criteria for Liver Failure in Southeast China: A Multicenter Retrospective Cohort Study Between 2018 and 2020.
Journal: Gastroenterology research and practice
Published: October 09, 2023
A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients.
Journal: Frontiers in medicine
Published: June 20, 2023
BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion.
Journal: Nature communications
Published: November 27, 2022
Decreased frequency of a novel T-lymphocyte subset, CD3+ CD4- CD7+ CD57- T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression.
Journal: Journal of medical virology
Published: July 07, 2022
IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response.
Journal: Journal of clinical and translational hepatology
Published: June 18, 2022
Manganese Breaks the Immune Tolerance of HBs-Ag.
Journal: Open forum infectious diseases
Published: July 29, 2020
Last Updated: 09/26/2026